Sign in

CIK 0001447028

  • Non-accelerated filer
  • Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980597776
Phone
+1 604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4/A Open-market sale Chief Scientific Officer sold 4,250 shares at $9.51 ($40,436)
  6. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $9.51 ($40,436)
  7. 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $10.00 ($100,000)
  8. 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $8.68 ($173,560)
  9. 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $8.20 ($164,000)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Option exercise President & CEO acquired 27,007 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 14 · 274 filings